| Products/Services Used | Details | Operation |
|---|---|---|
| Peptide Synthesis> | PBMCs were incubated with specific peptides (GenScript, USA or Auspep, Australia) at 10 μM in RPMI (Gibco, USA) as described (17, 20, 21). A gene encoding the extracellular domain of HLA-B*35:01 with the CD8 binding site mutations Q226K and D227A was designed and made synthetically with a C-terminal BirA tag (GenScript). | Get A Quote |
Cross-reactive αβ T cell receptors (TCRs) recognizing multiple peptide variants can provide effective control of rapidly evolving viruses yet remain understudied. By screening 12 naturally occurring influenza-derived HLA-B*35:01-restricted nucleoprotein (NP)418-426 epitopes (B*35:01-NP418) that emerged since 1918 within influenza A viruses, including 2024 A/H5N1 viruses, we identified functional broadly cross-reactive T cells universally recognizing NP418 variants. Binding studies demonstrated that TCR cross-reactivity was concomitant with diminished antigen sensitivity. Primary human B*35:01/NP418+CD8+ T cell lines displayed reduced cross-reactivity in the absence of CD8 coreceptor binding, validating the lo... More